Company Overview and News

Singapore home prices rise fastest in almost 8 years in the first quarter

2018-04-02 scmp
The island state’s housing market is recovering from a 4-year; price rise boosted by pent-up demand and stronger economic growth
Upvote Downvote

Property stocks decline following higher buyer's stamp duty - Channel NewsAsia

2018-02-20 channelnewsasia
SINGAPORE: Property-related stocks saw a decline on Tuesday (Feb 20), a day after the Government announced in the Budget speech that the Buyer’s Stamp Duty (BSD) would be raised.
Upvote Downvote

ASX ends flat after late surge

Australian shares managed to claw back from early losses to end the day barely changed, as banks came under a bit of selling pressure but earnings and broker moves helped limit downside.
Upvote Downvote

Singapore property stocks fall on higher home purchase tax

2018-02-20 themalaymailonline
Stamp duty on the portion of a property’s price above S$1 million will be raised effective immediately, to 4 per cent from 3 per cent, the government said in its budget on Monday. — Reuters picSINGAPORE, Feb 20 — Singapore property stocks declined after the government raised taxes on home purchases of more than S$1 million (RM2.9 million), just as the housing market starts to recover from a four-year slump.
Upvote Downvote

Singapore Budget 2018: Winners and losers

2018-02-19 themalaymailonline
Singapore Budget 2018 aims to financially equip the city state for financial pressures that will come with a rapidly aging population. — Reuters file pic SINGAPORE, Feb 19 — A range of tax increases, including a 2 percentage point increase to 9 per cent in the goods and services levy, were unveiled by Singapore Finance Minister Heng Swee Keat in his budget speech to Parliament as among measures to financially equip the city state for financial pressures that will come with a rapidly aging population.
Upvote Downvote

Singapore property stocks show ‘fatigue’ with surge in enblocs

2018-02-19 themalaymailonline
Collective apartment sales in the first two months of 2018 totalled over S$3.1 billion (RM9.1 billion), almost twice the S$1.66 billion seen in the last peak of the enbloc market in 2007. — TODAY picSINGAPORE, Feb 19 — A spate of enbloc sales, coupled with a rebound in the property market at the start of the year, may indicate that Singapore developers will be more cautious in adding to landbanks and about their pricing strategies, analysts say.
Upvote Downvote

Dispute over property defects at The Sail resolved out of court - Channel NewsAsia

2018-02-09 channelnewsasia
SINGAPORE: Residents of The Sail @ Marina Bay have resolved a long-running dispute with the luxury condominium's developer Glengary and contractor Dragages Singapore over what they claim are property defects.
Upvote Downvote

DBS, CDL among firms recognised for gender-equality efforts on Bloomberg index - Channel NewsAsia

2018-01-23 channelnewsasia
SINGAPORE: Two Singaporean firms, DBS Bank and City Developments Limited (CDL), were among 104 recognised for their gender-equality efforts in the 2018 Bloomberg Gender-Equality Index launched on Monday (Jan 22). 
Upvote Downvote

'Long Winter' Seen Ending for Singapore Home Prices: Survey - Bloomberg

2018-01-23 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Listed developer CDL sued over property defects - Channel NewsAsia

2018-01-18 channelnewsasia
SINGAPORE: For almost eight years, residents at The Sail @ Marina Bay had to bear with the stench from the rubbish chutes of their million-dollar homes.
Upvote Downvote

Singapore Property Rebound Just Starting as Prices Seen Jumping - Bloomberg

2018-01-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Singapore property seen on path to recovery after prolonged slump

2018-01-10 themalaymailonline
Real estate services firm Colliers today said average home prices may rise by 17 per cent over 2018-2021. — TODAY picSINGAPORE, January 10 — Singapore’s housing market is expected to build on its recovery over 2018, analysts say, as private home prices marked their first annual rise in four years.
Upvote Downvote

Singapore authorities' housing market warning may fall on deaf ears

2017-12-22 in.reuters
SINGAPORE (Reuters) - Singapore’s authorities are concerned the island-state’s property market could be setting itself up for a fall.
Upvote Downvote

'Stars are aligned' for Singapore stocks to go higher in 2018: Analysts - Channel NewsAsia

2017-12-17 channelnewsasia
SINGAPORE: The likes of banking heavyweights, developers and property trusts will continue to lead the charge next year for Singapore’s stock market, which could see gains of as much as 11 per cent, according to market analysts.
Upvote Downvote

Millennium & Copthorne investor trio tries to derail 'low-ball' bid by majority owners

A trio of shareholders in hotelier Millennium & Copthorne are trying to derail what they call a “low-ball” offer for the company by its majority owners.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 177797305